ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-ΚB/NLRP3 signaling pathway

Deng, Yan-fang; Xu, Qian-qian; Chen, Tian-qi; Ming, Jia-xiong; Wang, Ya-fen; Mao, Li-na; Zhou, Jia-jun; Sun, Wei-guang*; Zhou, Qun*; Ren, Hong*; Zhang, Yong-hui*华中科技大学; 1
PHYTOMEDICINE2022-9DOI: 10.1016/j.phymed.2022.154241
13被引21阅读
引用收藏
分享

摘要

Background: Non-alcoholic steatohepatitis (NASH) has replaced viral hepatitis as the main driver of the rising morbidity and mortality associated with cirrhosis and liver cancer worldwide, while no FDA-approved therapies are currently known. Kinsenoside (KD), naturally isolated from Anoectochilus roxburghii, possesses multiple biological activities, including lipolysis, anti-inflammation, and hepatoprotection. However, the effects of KD on NASH remain unclear.Purpose: This study aimed to explore the roles of KD in NASH and its engaged mechanisms.Methods: Two typical animal models of NASH, mice fed a methionine-choline-deficient (MCD) diet (representing non-obese NASH) and mice fed a high-fat and-fructose diet (HFFD) (representing obese NASH), were used to investigate the effect of KD on NASH in vivo. Transcriptome sequencing was performed to elucidate the underlying mechanisms of KD. Lipopolysaccharide (LPS)-stimulated THP-1 cells and transforming growth factor beta 1 (TGF-beta 1)-activated LX-2 cells were applied to further explore the effects and mechanisms of KD in vitro.Results: The intragastric administration of KD remarkably alleviated MCD/HFFD-induced murine NASH almost in a dose-dependent manner. Specifically, KD reduced lipid accumulation, inflammation, and fibrosis in the liver of NASH mice. KD ameliorated alanine aminotransferase (ALT), aspartate aminotransferase (AST), superoxide dismutase (SOD), and malondialdehyde (MDA) abnormalities. In addition, it decreased the level of serum proinflammatory factors (IL-12p70, IL-6, TNF-alpha, MCP-1, IFN-gamma) and the hepatic expression of typical fibrosis related molecules (alpha-SMA, Col-I, TIMP-1). Mechanically, KD attenuated the MCD/HFFD-induced NASH through the inhibition of the NF-Kappa B/NLRP3 signaling pathway. Consistently, KD reduced inflammation stimulated by LPS in THP-1 cells via suppressing the NF-Kappa B/NLRP3 pathway. Furthermore, it prevented the activation of LX-2 cells directly, by inhibiting the proliferation stimulated by TGF-beta 1, and indirectly, by inactivating the NLRP3 inflammasome in macrophages.Conclusion: For the first time, the practical improvement of NASH by KD was revealed. Our study found that KD exerted its alleviative effects on NASH through the inhibition of the NF-Kappa B/NLRP3 signaling pathway. Given its hepatoprotective and nontoxic properties, KD has the potential to be a novel and effective drug to treat NASH.

学科与关键词

关键词
NASHSteatosisInflammationFibrosisNLRP3Kinsenoside
相关
加载中…
  • Butyrolactone I attenuates inflammation in murine NASH by inhibiting the NF-KB signaling pathway
    Tian-qi, Chen; Yan-fang, Deng; Yan-yan, Wang*; Yong-hui, Zhang*Biochemical and Biophysical Research Communications, 2022, 626: 167-174.被引 1
  • Neferine ameliorates nonalcoholic steatohepatitis through regulating AMPK pathway
    Wang, Ming-Yue; Zhang, Shao-Shi; An, Meng - Fei; Xia, Yue-fei; Fan, Mao-Si; Sun, Ze-Rui; Zhang, Li-Juan; Zhao, Yun-Li*; Sheng, Jun*; Wang, Xuan-Jun*PHYTOMEDICINE, 2023, 114: 154798.
  • Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling
    Lan, Tian; Jiang, Shuo; Zhang, Jing; Weng, Qiqing; Yu, Yang; Li, Haonan; Tian, Song; Ding, Xin; Hu, Sha; Yang, Yiqi; Wang, Weixuan; Wang, Lexun; Luo, Duosheng; Xiao, Xue; Piao, Shenghua; Zhu, Qing; Rong, Xianglu; Guo, JiaoHepatology, 2022, 76(1): 155-171.被引 31
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2022-09
卷期
第 104 卷
页码
154241
DOI
10.1016/j.phymed.2022.154241
语言
GERMAN
期刊等级
2区
成果收录
SCIE
资助标注
Program for Changjiang Scholars of Ministry of Education of People's Republic of China [T2016088]; National Natural Science Foundation for Distinguished Young Scholars [81725021]; Innovative Research Groups of National Natural Science Foundation of China [81721005]; Academic Frontier Youth Team of HUST; Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College (HUST); Science and Technology Major Special Fund of Hubei Province [2020ACA019]

作者

  • D

    Deng, Yan-fang (第一作者)

    huazhong univ sci & technol

  • X

    Xu, Qian-qian

    huazhong univ sci & technol

查看全部 11 位作者收起作者
  • C

    Chen, Tian-qi

    1 · china three gorges univ

  • M

    Ming, Jia-xiong

    huazhong univ sci & technol

  • W

    Wang, Ya-fen

    huazhong univ sci & technol

  • M

    Mao, Li-na

    huazhong univ sci & technol

  • Z

    Zhou, Jia-jun

    huazhong univ sci & technol

  • S

    Sun, Wei-guang (通讯)

    huazhong univ sci & technol

  • Z

    Zhou, Qun (通讯)

    huazhong univ sci & technol

  • R

    Ren, Hong (通讯)

    huazhong univ sci & technol

  • Z

    Zhang, Yong-hui (通讯)

    huazhong univ sci & technol

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417